Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost ...

Minocycline and doxycycline are prescribed in divided doses of 100-200 mg/day and can be lowered to 50 mg/day with improvement ... isotretinoin, and dapsone. Spironolactone, an androgen receptor ...

Additionally, CXCL9 levels were obtained and elevated to 50 776 ... tapered to 2.5 mg daily for an additional 3 weeks. The steroid was then discontinued. The patient was maintained on prophylactic ...

The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive ...

The FDA approved oral iptacopan (Fabhalta; Novartis) to reduce proteinuria in adults with C3 glomerulopathy (C3G), according ...

The MG Comet Blackstorm edition has been launched at a price of Rs 7.80 lakh (ex-showroom), plus Rs 2.50 per km for battery rental. The Comet Blackstorm is based on the top Exclusive variant of ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...

The bioequivalence of a proprietary liquid dapsone preparation and commercially available dapsone tablets was studied. Twelve adult volunteers received dapsone doses with 8 oz of water one to two ...

Few rappers have attracted as much controversy and media attention as 50 Cent over the last two decades. From his breakout album “Get Rich or Die Tryin'” to his recent business ventures ...

The Note 50 series is right around the corner. And we do mean that - there really isn't much waiting left to do for the devices. Infinix has officially started teasing the Note 50 series in ...

Although the Dow Jones EuroStoxx 50 was only introduced in February 1998, its prices were calculated retroactively back to the year 1986. (read more) The EuroStoxx 50 consists of the shares of the ...

Now, I have been more guilty than most in commissioning lots of op-eds, columns on Elon Musk in the last 50 days. But I really think he has been the story. He’s my pick for this first halfway point.